test

Jennifer Ciresi

@Redmile Group, Llc

Latest period2024 - Q3ReportedManaged Assets$1.697BTotal holdings63
Assets growth rate2.63%Assets growth rate (2-Q avg)-18.33%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Redmile Group, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 63 positions.

Assets under management

The assets under management (AUM) of Redmile Group, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.697B in assets, with a quarterly growth rate of 2.63% and a 2-quarter average growth rate of -18.33%. The portfolio is managed by Jennifer Ciresi, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ISRGIntuitive Surgical Inc
Recent Activity
Decreased -32.99%
0.78%
$13.116M
26,698 shares@ $491.27 avg price
SYKStryker Corporation
Recent Activity
Decreased -17.07%
0.7%
$11.828M
32,741 shares@ $361.27 avg price
ETNB89bio Inc
Recent Activity
Decreased -10.07%
0.69%
$11.617M
1.57M shares@ $7.4 avg price
ARDXArdelyx Inc
Recent Activity
Decreased -11.73%
0.68%
$11.443M
1.661M shares@ $6.89 avg price
ALXOAlx Oncology Hldgs Inc
Recent Activity
Decreased -4.95%
0.42%
$6.983M
3.837M shares@ $1.82 avg price
VERVVerve Therapeutics Inc
Recent Activity
Decreased -5.46%
0.4%
$6.695M
1.383M shares@ $4.84 avg price
ACIUAc Immune Sa
Recent Activity
Decreased -6.28%
0.38%
$6.404M
1.694M shares@ $3.78 avg price
CYTKCytokinetics Inc
Recent Activity
Decreased -13.18%
0.31%
$5.128M
97,116 shares@ $52.81 avg price
VTYXVentyx Biosciences Inc
Recent Activity
Decreased -2.62%
0.28%
$4.594M
2.107M shares@ $2.19 avg price
BOLDBoundless Bio Inc
Recent Activity
Decreased -1.06%
0.21%
$3.552M
1.024M shares@ $3.48 avg price